Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

PEPTIM PEptides Promoting Tolerogenic Interactions with Microbiota

Coordinator
Agencia Estatal Consejo Superior De Investigaciones Cientificas, Spain
Runs
1 September 2025 to 31 August 2027
Status
Running
EU funding
€194k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101210695

What the project is doing

In the project's own words, from its summary on CORDIS.

Food allergy (FA) is a growing health issue in urbanized countries, notably affecting children, with prevalence rates of 5.7% to 16.6% in Europe due to egg and cow's milk allergies. Western lifestyle factors and environmental exposures contribute to FA by causing inflammation and damaging epithelial barriers. Dysbiosis, an imbalance in gut microbiota, impairs immune development and tolerance, leading to an exaggerated Th2 response and reduced RORγt+ regulatory T cells (iTregs).

Current FA treatments are limited, highlighting the need for new approaches. Bioactive peptides from enzymatically hydrolyzed allergens offer a promising alternative to traditional oral immunotherapy (OIT), potentially reducing allergenicity and side effects. These peptides may induce tolerance more effectively and positively influence gut microbiota. The PEPTIM project aims to explore the mechanisms of oral tolerance with bioactive peptides by analyzing immune responses and microbiota changes.

Using murine models and in vitro cultures, the study will investigate the impact of these peptides on gut microbiota and intestinal function. Objectives include: (1) Comparing immune and microbiota changes with intact versus bioactive peptides during OIT, (2) Developing models to study microbial roles in tolerance, and (3) Examining interactions between bioactive peptides, microbial communities, and gut epithelial barrier.

This research seeks to enhance understanding of FA mechanisms and explore new therapeutic strategies.

Topics

Who is involved

OrganisationCityCountryRole
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI